ApoCIII as a Cardiovascular Risk Factor and Modulation by the Novel Lipid-Lowering Agent Volanesorsen
Crossref DOI link: https://doi.org/10.1007/s11883-017-0697-3
Published Online: 2017-11-09
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rocha, Natalia A.
East, Cara
Zhang, Jun
McCullough, Peter A.
License valid from 2017-11-09